SCHEMBL7684426

SCHEMBL7684426

CSc1c[c]c(OC(F)F)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23411833 0.81 MAPT (0.33)
SCHEMBL1068463 0.75 LMNA (0.32)
SCHEMBL900696 0.74 DRD1 (0.38)
SCHEMBL900083 0.72 HTT (0.30)
SCHEMBL4918787 0.72 MEN1 (0.31)
SCHEMBL1064959 0.72 MAPT (0.40)
SCHEMBL1068484 0.71
SCHEMBL1067893 0.71
SCHEMBL359672 0.71
SCHEMBL4917371 0.70 LMNA (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436961-B1 SUBSTANCE P RECEPTOR ANTAGONIST; 2-PHENYL-3-BENZYLAMINOPIPERIDINES PFIZER INC 2002-08-20 US claimed
CN-108368116-B Janus kinase inhibitor, composition and application thereof 豪夫迈·罗氏有限公司 2021-06-11 CN disclosed